Blinatumomab infusion interruptions in pediatric patients rarely lead to readmission.

Moody J, Barker PJ, Sciasci J, Pauley JL, Bragg A, McMillan C, Triplett BM, Swanson HD

Open source

DOI
10.1002/pbc.31223
Published
2024 Oct
Container
Pediatric blood & cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pbc.31223,
  title = {Blinatumomab infusion interruptions in pediatric patients rarely lead to readmission.},
  author = {Moody J and Barker PJ and Sciasci J and Pauley JL and Bragg A and McMillan C and Triplett BM and Swanson HD},
  year = {2024},
  journal = {Pediatric blood \& cancer},
  doi = {10.1002/pbc.31223},
  url = {https://doi.org/10.1002/pbc.31223}
}

RIS

TY  - JOUR
TI  - Blinatumomab infusion interruptions in pediatric patients rarely lead to readmission.
AU  - Moody J
AU  - Barker PJ
AU  - Sciasci J
AU  - Pauley JL
AU  - Bragg A
AU  - McMillan C
AU  - Triplett BM
AU  - Swanson HD
PY  - 2024
JO  - Pediatric blood & cancer
DO  - 10.1002/pbc.31223
UR  - https://doi.org/10.1002/pbc.31223
ER  - 

APA

J, M., PJ, B., J, S., JL, P., A, B., C, M., BM, T., & HD, S. (2024). Blinatumomab infusion interruptions in pediatric patients rarely lead to readmission.. Pediatric blood & cancer. https://doi.org/10.1002/pbc.31223

Source records